Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

[Effects of folic acid on cerebrovascular and cancer risks].

Martin-Du Pan RC, Mercan D.

Rev Med Suisse. 2012 Feb 15;8(328):375-9. French.

PMID:
22397069
2.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
3.

[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].

Méndez-González J, Rodríguez-Millán E, Julve J, Blanco-Vaca F.

Rev Neurol. 2010 Feb 16-28;50(4):235-44. Review. Spanish.

4.
5.

Homocysteine, folic acid, B vitamins and cardiovascular risk.

Blacher J, Safar ME.

J Nutr Health Aging. 2001;5(3):196-9. Review.

PMID:
11458292
6.
7.

The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?

Abraham JM, Cho L.

Cleve Clin J Med. 2010 Dec;77(12):911-8. doi: 10.3949/ccjm.77a.10036. Review.

PMID:
21147945
8.

Homocysteine: is it a clinically important cardiovascular risk factor?

Lentz SR, Haynes WG.

Cleve Clin J Med. 2004 Sep;71(9):729-34. Review.

PMID:
15478704
9.

Homocysteine, B-vitamins and CVD.

McNulty H, Pentieva K, Hoey L, Ward M.

Proc Nutr Soc. 2008 May;67(2):232-7. doi: 10.1017/S0029665108007076. Review.

PMID:
18412997
10.

Homocysteine lowering and cardiovascular disease risk: lost in translation.

Marcus J, Sarnak MJ, Menon V.

Can J Cardiol. 2007 Jul;23(9):707-10. Review.

11.

Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction.

Ciaccio M, Bellia C.

Curr Clin Pharmacol. 2010 Feb;5(1):30-6. Review.

PMID:
20236081
12.
13.

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

B-Vitamin Treatment Trialists' Collaboration.

Am Heart J. 2006 Feb;151(2):282-7. Review.

PMID:
16442889
14.

Homocysteine, B vitamins, and risk of cardiovascular disease.

Robinson K.

Heart. 2000 Feb;83(2):127-30. No abstract available.

15.

[Group B vitamins as new variables related to the cardiovascular risk].

Granieri M, Bellisarii FI, De Caterina R.

Ital Heart J Suppl. 2005 Jan;6(1):1-16. Review. Italian.

PMID:
15776726
16.

Vitamins and minerals 4: overview of folate and the B vitamins.

Thompson J.

Community Pract. 2006 Jun;79(6):197-8. Review.

PMID:
16780289
17.

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.

Siragusa S, Malato A, Cigna V, Anastasio R, Coco LL, Casuccio A, Ciaccio M.

Thromb Res. 2007;121(1):51-3. Epub 2007 Apr 25. No abstract available.

PMID:
17462714
18.

Folate and homocysteine.

Young IS, Woodside JV.

Curr Opin Clin Nutr Metab Care. 2000 Nov;3(6):427-32. Review.

PMID:
11085827
19.

Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.

Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T.

Nutrition. 2007 Mar;23(3):242-7. Epub 2007 Feb 22.

PMID:
17321110
20.

Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease.

Stott DJ, MacIntosh G, Lowe GD, Rumley A, McMahon AD, Langhorne P, Tait RC, O'Reilly DS, Spilg EG, MacDonald JB, MacFarlane PW, Westendorp RG.

Am J Clin Nutr. 2005 Dec;82(6):1320-6.

Supplemental Content

Support Center